Glaxosmithkline Pharmaceutical Q1 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
3,200.00
6.00 (0.19%)
6.00 (0.19%)Volume2.21 K
Updated: Fri 20 Jun, 2025 | 15:28:32
NSE
3,213.5014.30 (0.45%)
14.30 (0.45%)Volume1.24 L
Updated: Fri 20 Jun, 2025 | 15:53:52
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glaxosmithkline Pharmaceutical Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 24 | Mar 25 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 814.65 | 974.37 | -12.38% | 814.65 | N/A |
| Selling/ General/ Admin Expenses Total | 151.28 | 152.97 | -12.47% | 151.28 | N/A |
| Depreciation/ Amortization | 16.41 | 14.72 | -9.34% | 16.41 | N/A |
| Other Operating Expenses Total | 137.56 | 136.27 | 3.76% | 137.56 | N/A |
| Total Operating Expense | 600.52 | 655.90 | -13.05% | 600.52 | N/A |
| Operating Income | 214.13 | 318.47 | -10.47% | 214.13 | N/A |
| Net Income Before Taxes | 249.40 | 358.57 | -7.84% | 249.40 | N/A |
| Net Income | 182.33 | 262.87 | -6.25% | 182.33 | N/A |
| Diluted Normalized EPS | 10.76 | 15.51 | -5.38% | 10.76 | N/A |